$HBIO
HARVARD BIOSCIENCE INC Stock $hbio

$hbio Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000117184322003220 Filed on May 04, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$28.78M	$26.99M
YoY Change	6.63%	13.54%
Cost Of Revenue	$12.60M	$11.56M
YoY Change	9.02%	7.13%
Gross Profit	$16.18M	$15.43M
YoY Change	4.83%	18.86%
Gross Profit Margin	56.21%	57.18%
Selling, General & Admin	$13.01M	$11.72M
YoY Change	11.03%	-5.02%
% of Gross Profit	80.44%	75.94%
Research & Development	$3.220M	$2.487M
YoY Change	29.47%	-0.12%
% of Gross Profit	19.9%	16.12%
Depreciation & Amortization	$382.0K	$445.0K
YoY Change	-14.16%	-8.06%
% of Gross Profit	2.36%	2.88%
Operating Expenses	$22.89M	$15.67M
YoY Change	46.07%	-3.6%
Operating Profit	-$6.712M	-$239.0K
YoY Change	2708.37%	-92.7%
Interest Expense	-$384.0K	-$411.0K
YoY Change	-6.57%	-68.36%
% of Operating Profit
Other Income/Expense, Net	-$306.0K	-$445.0K
YoY Change	-31.24%	-62.54%
Pretax Income	-$7.018M	-$684.0K
YoY Change	926.02%	-84.67%
Income Tax	-$100.0K	-$15.00K
% Of Pretax Income
Net Earnings	-$6.880M	-$669.0K
YoY Change	928.4%	-85.19%
Net Earnings / Revenue	-23.91%	-2.48%
Basic Earnings Per Share	-$0.17	-$0.02
Diluted Earnings Per Share	-$166.9K	-$16.84K
COMMON SHARES
Basic Shares Outstanding	41.22M	39.79M
Diluted Shares Outstanding	41.22M	39.79M

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.433M	$5.800M
YoY Change	-6.33%	-1.69%
Cash & Equivalents	$5.433M	$5.815M
Short-Term Investments
Other Short-Term Assets	$5.030M	$3.658M
YoY Change	37.51%	-1.53%
Inventory	$28.71M	$22.68M
Prepaid Expenses
Receivables	$20.27M	$17.07M
Other Receivables	$5.030M	$3.600M
Total Short-Term Assets	$59.45M	$49.22M
YoY Change	20.77%	2.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.499M	$3.699M
YoY Change	-5.41%	-17.58%
Goodwill	$57.36M	$58.22M
YoY Change	-1.48%	2.51%
Intangibles	$25.88M	$31.89M
YoY Change	-18.85%	-13.36%
Long-Term Investments
YoY Change
Other Assets	$5.258M	$812.0K
YoY Change	547.54%	-56.83%
Total Long-Term Assets	$98.60M	$102.0M
YoY Change	-3.36%	-5.61%
TOTAL ASSETS
Total Short-Term Assets	$59.45M	$49.22M
Total Long-Term Assets	$98.60M	$102.0M
Total Assets	$158.0M	$151.2M
YoY Change	4.49%	-3.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.218M	$6.416M
YoY Change	-3.09%	-3.15%
Accrued Expenses	$7.725M	$5.400M
YoY Change	43.06%	-27.51%
Deferred Revenue	$3.956M	$3.637M
YoY Change	8.77%	-0.98%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.000M	$2.250M
YoY Change	33.33%	-29.69%
Total Short-Term Liabilities	$27.23M	$20.72M
YoY Change	31.41%	-11.74%
LONG-TERM LIABILITIES
Long-Term Debt	$46.24M	$41.60M
YoY Change	11.16%	-10.11%
Other Long-Term Liabilities	$598.0K	$2.848M
YoY Change	-79.0%	230.39%
Total Long-Term Liabilities	$46.84M	$44.45M
YoY Change	5.39%	-5.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$27.23M	$20.72M
Total Long-Term Liabilities	$46.84M	$44.45M
Total Liabilities	$81.67M	$74.13M
YoY Change	10.16%	-7.62%
SHAREHOLDERS EQUITY
Retained Earnings	-$139.6M	-$133.1M
YoY Change	4.88%	3.07%
Common Stock	$226.7M	$235.2M
YoY Change	-3.64%	2.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares		$7.746M
Shareholders Equity	$76.38M	$77.12M
YoY Change
Total Liabilities & Shareholders Equity	$158.0M	$151.2M
YoY Change	4.49%	-3.21%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$6.880M	-$669.0K
YoY Change	928.4%	-85.19%
Depreciation, Depletion And Amortization	$382.0K	$445.0K
YoY Change	-14.16%	-8.06%
Cash From Operating Activities	-$1.986M	$1.037M
YoY Change	-291.51%	-63.88%
INVESTING ACTIVITIES
Capital Expenditures	$471.0K	$151.0K
YoY Change	211.92%	-37.34%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$471.0K	-$301.0K
YoY Change	56.48%	24.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$936.0K	$500.0K
YoY Change	87.2%	-89.65%
Cash From Financing Activities	$94.00K	-$3.141M
YoY Change	-102.99%	-38.06%
NET CHANGE
Cash From Operating Activities	-$1.986M	$1.037M
Cash From Investing Activities	-$471.0K	-$301.0K
Cash From Financing Activities	$94.00K	-$3.141M
Net Change In Cash	-$2.388M	-$2.502M
YoY Change	-4.56%	2.0%
FREE CASH FLOW
Cash From Operating Activities	-$1.986M	$1.037M
Capital Expenditures	$471.0K	$151.0K
Free Cash Flow	-$2.457M	$886.0K
YoY Change	-377.31%	-66.31%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6333000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3220000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2487000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1466000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1464000	USD
CY2022Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	5191000	USD
CY2021Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	22889000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	15670000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6712000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-239000	USD
CY2022Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-384000	USD
CY2021Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-411000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	78000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-34000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-306000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-445000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7018000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-684000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-138000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-139554000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-132674000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-10726000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-10027000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	76375000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	83401000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	158044000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	162344000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28778000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26989000	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12601000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11558000	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	16177000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	15431000	USD
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6687000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5386000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6325000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	20274000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21834000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	28711000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	27587000	USD
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	5030000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	4341000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	59448000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	61583000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3499000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3415000	USD
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	41241449
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0.01
CY2021Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0.01
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41241449
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41241449
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41142876
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41142876
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1500000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5433000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7821000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6605000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6897000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	57356000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	57689000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	25878000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	27385000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5258000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5375000	USD
CY2022Q1	us-gaap	Assets Assets	158044000	USD
CY2021Q4	us-gaap	Assets Assets	162344000	USD
CY2022Q1	us-gaap	Secured Debt Current SecuredDebtCurrent	2720000	USD
CY2021Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	3235000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2151000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2142000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	6218000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4911000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3956000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4266000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	12181000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10762000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	27226000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	25316000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	46244000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	45095000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1442000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1558000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6159000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6488000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	598000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	486000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	81669000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	78943000	USD
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	452000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	452000	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	226203000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	225650000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	471000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6880000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-669000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41219000
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39787000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6880000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-669000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-699000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1325000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7579000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1994000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	83401000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	31000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	501000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1023000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6880000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-699000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	76375000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	76681000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1924000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2021Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	464000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	968000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-669000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1325000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	77115000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6880000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-669000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	382000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	445000	USD
CY2022Q1	hbio	Amortization Of Intangible Assets Including Amounts Related To Discontinued Operation AmortizationOfIntangibleAssetsIncludingAmountsRelatedToDiscontinuedOperation	1466000	USD
CY2021Q1	hbio	Amortization Of Intangible Assets Including Amounts Related To Discontinued Operation AmortizationOfIntangibleAssetsIncludingAmountsRelatedToDiscontinuedOperation	1464000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	70000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	70000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1023000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	968000	USD
CY2022Q1	hbio	Deferred Income Tax Expense Benefit Including Discontinued Operation DeferredIncomeTaxExpenseBenefitIncludingDiscontinuedOperation	123000	USD
CY2021Q1	hbio	Deferred Income Tax Expense Benefit Including Discontinued Operation DeferredIncomeTaxExpenseBenefitIncludingDiscontinuedOperation	53000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1506000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-584000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1308000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	602000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	466000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	94000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2729000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-245000	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-300000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-135000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-85000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-696000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1986000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1037000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	151000	USD
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-0	USD
CY2021Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	150000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-471000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-301000	USD
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1500000	USD
CY2021Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2022Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	-0	USD
CY2021Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	4000000	USD
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	936000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	500000	USD
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	-0	USD
CY2021Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	101000	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	31000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1924000	USD
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	501000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	464000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	94000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3141000	USD
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-25000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-97000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2388000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2502000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7821000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8317000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5433000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5815000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	383000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	458000	USD
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	107000	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-113000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	57689000	USD
CY2022Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-333000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	57356000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	64672000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	39028000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	25644000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	64892000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	37745000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27147000	USD
CY2022Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	234000	USD
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	238000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	25878000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	27385000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1500000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	4366000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5728000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	5427000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4109000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2368000	USD
CY2022Q1	hbio	Finitelived Intangible Asset Expected Amortization After Year Four FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour	3646000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	25644000	USD
CY2022Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	6798000	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	5646000	USD
CY2022Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3439000	USD
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3410000	USD
CY2022Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	18474000	USD
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	18531000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	28711000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	27587000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2878000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6048000	USD
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	396000	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	480000	USD
CY2022Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	242000	USD
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	240000	USD
CY2022Q1	hbio	Customer Related Costs CustomerRelatedCosts	2058000	USD
CY2021Q4	hbio	Customer Related Costs CustomerRelatedCosts	2265000	USD
CY2022Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent	4814000	USD
CY2021Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	0	USD
CY2022Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	141000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	224000	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1653000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1505000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	12181000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10762000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	8630000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y6M
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y8M12D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.093	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.093	pure
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	504000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	517000	USD
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	64000	USD
CY2021Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	46000	USD
CY2022Q1	us-gaap	Sublease Income SubleaseIncome	25000	USD
CY2021Q1	us-gaap	Sublease Income SubleaseIncome	25000	USD
CY2022Q1	us-gaap	Lease Cost LeaseCost	543000	USD
CY2021Q1	us-gaap	Lease Cost LeaseCost	538000	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	594000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	611000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	39000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6605000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6897000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2151000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2142000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6159000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6488000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	8310000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1611000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2133000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1765000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1019000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	980000	USD
CY2022Q1	hbio	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	3871000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	11379000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3069000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	8310000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1404816
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.10
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	10987
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.78
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	3126
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.79
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1390703
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.10
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1023000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	968000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	8200000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y2M12D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.92
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41219000
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39787000
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2021Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41219000
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39787000
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3500000
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4500000
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1050000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1120000	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	48964000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	48330000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	3000000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3515000	USD
CY2022Q1	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	280000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	280000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	46244000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	45095000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28778000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26989000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28778000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26989000	USD
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3956000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4266000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	700000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1200000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	136000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	227000	USD
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-6000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5000	USD
CY2022Q1	hbio	Accounts Receivable Allowance For Credit Loss Chargeoffs And Other Reoveries AccountsReceivableAllowanceForCreditLossChargeoffsAndOtherReoveries	-6000	USD
CY2021Q1	hbio	Accounts Receivable Allowance For Credit Loss Chargeoffs And Other Reoveries AccountsReceivableAllowanceForCreditLossChargeoffsAndOtherReoveries	-22000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	136000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	254000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-100000	USD
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.020	pure
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.022	pure

Files In Submission

Name	View Source	Status
0001171843-22-003220-index-headers.html	Edgar Link	pending
0001171843-22-003220-index.html	Edgar Link	pending
0001171843-22-003220.txt	Edgar Link	pending
0001171843-22-003220-xbrl.zip	Edgar Link	pending
ex_362798.htm	Edgar Link	pending
ex_362799.htm	Edgar Link	pending
ex_362800.htm	Edgar Link	pending
ex_362801.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hbio-20220331.xsd	Edgar Link	pending
hbio-20220331_cal.xml	Edgar Link	unprocessable
hbio-20220331_def.xml	Edgar Link	unprocessable
hbio-20220331_lab.xml	Edgar Link	unprocessable
hbio-20220331_pre.xml	Edgar Link	unprocessable
hboi20220331_10q.htm	Edgar Link	pending
hboi20220331_10q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HBIO
HARVARD BIOSCIENCE INC Stock $hbio

2022 Q1 Form 10-Q Financial Statement

#000117184322003220 Filed on May 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HBIO HARVARD BIOSCIENCE INC Stock $hbio

2022 Q1 Form 10-Q Financial Statement

#000117184322003220 Filed on May 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HBIO
HARVARD BIOSCIENCE INC Stock $hbio